From: Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
Cancer type | Expression | Biological Function | Related genes | Roles | Refs |
---|---|---|---|---|---|
Acute myeloid leukemia | Upregulated | Proliferation, Cell cycle, Apoptosis | miR-188-5p/ZFP91 | Oncogene | [38] |
Breast cancer | Upregulated | Proliferation, cell cycle, invasion, migration, apoptosis | miR-143/RRS1 | Oncogene | [35] |
Lung cancer | Upregulated | Promote cell proliferation, invasion, migration | SUZ12, p21, Cyclin D1 | Oncogene | [26] |
Upregulated | Enhance radiotherapy resistance (promote cell proliferation, inhibit apoptosis) | miR-302a/MBNL3 | Oncogene | [42] | |
Upregulated | Promote cell proliferation, invasion and migration | miR-338-3p/ADAM17 | Oncogene | [50] | |
Upregulated | Promote cell proliferation, invasion, migration | E2F1/SBF2-AS1/miR-362-3p/GRB2 | Oncogene | [46] | |
Upregulated | Promote cell cycle and cell proliferation | miR-338-3p、miR-362-3p/E2F1 | Oncogene | [48] | |
Upregulated | Promote cell proliferation, inhibit apoptosis | FOXM1 | Oncogene | [47] | |
Osteosarcoma | Upregulated | Proliferation, invasion, migration | miR-30a/FOXA1 | Oncogene | [44] |
Pancreatic cancer | Upregulated | Promote cell proliferation, invasion, migration and EMT, inhibit apoptosis | miR-142-3p/TWF1 | Oncogene | [27] |
Upregulated | Promote cell proliferation, invasion and migration, inhibit apoptosis | miR-122-5p/XIAP | Oncogene | [43] | |
Cervical cancer | Upregulated | Proliferation, cell cycle, apoptosis | miR-361-5p/FOXM1 | Oncogene | [39] |
Colorectal cancer | Upregulated | Proliferation, invasion, migration | miR-619-5p/HDAC3 | Oncogene | [30] |
Papillary thyroid cancer | Upregulated | Proliferation, cell cycle,invasion, apoptosis | miR-431-5p/CDK14 | Oncogene | [40] |
Glioblastoma | Upregulated | Reduce temozolomide sensitivity, promote tumor cell DNA repair | Z1B1/SBF2-AS1/miR-151-3p/XRCC4 | Oncogene | [37] |
Upregulated | Promote angiogenesis (enhance endothelial cells viability, migration and tube formation) | NFAT5/miR-338-3p/EGFL7/ERK | Oncogene | [36] | |
Clear cell renal cell carcinoma | Upregulated | Proliferation, invasion, migration, apoptosis | miR-338-3p/ETS1 | Oncogene | [41] |
Hepatocellular carcinoma | Upregulated | Promote cell proliferation, invasion, migration and EMT | miR-140-5p/TGFBR1 | Oncogene | [28] |
Upregulated | Promote cell migration and invasion | miR-145-5p/SCAMP3 | Oncogene | [57] | |
Upregulated | Promote cell proliferation, invasion, migration and EMT | N-cadherin, vimentin | Oncogene | [29] | |
Gastric cancer | Upregulated | Proliferation, invasion, migration | miR-545/EMS1 | Oncogene | [31] |
Esophageal squamous cell carcinoma | Upregulated | Promote cell proliferation, invasion, migration and EMT, inhibit apoptosis | miR-494/PFN2 | Oncogene | [33] |
Upregulated | Promote cell proliferation and inhibit apoptosis | miR-338-3p/miR-362-3p/E2F1 | Oncogene | [34] | |
Upregulated | Promote cell proliferation, invasion and migration | CDKN1A | Oncogene | [32] |